TOP 10 PHARMA COMPANIES IN

INDIA 2015

A BRIEF BACKGROUND OF THE INDIAN PHARMACEUTICAL

INDUSTRY

The Indian pharmaceuticals market is third largest in terms of volume and thirteen largest in terms of
value, as per a pharmaceuticals sector analysis report by equity master. The Indian pharmaceutical
industry is estimated to grow at 20 per cent compound annual growth rate (CAGR) over the next five
years, as per India Ratings, a Fitch Group company. We expect the domestic Pharma market to grow
at 10-12 per cent in FY15 as compared to 9 per cent in FY14, as per a recent report from Centrum
Broking. The Union Cabinet has given its approval to amend the existing FDI policy in the
pharmaceutical sector in order to cover medical devices. The Cabinet has allowed FDI up to 100 per
cent under the automatic route for manufacturing of medical devices subject to specified conditions.
The Indian pharma market size is expected to grow to US$ 85 billion by 2020. The growth in Indian
domestic market will be on back of increasing consumer spending, rapid urbanisation, raising
healthcare insurance and so on.Going forward, better growth in domestic sales will depend on the
ability of companies to align their product portfolio towards chronic therapies for diseases such as
such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers are on the rise.

LIST OF 17 PHARMACEUTICAL GIANTS OF INDIA CONSIDERED FOR THE TOP 10

POSITIONS

Method of Ranking:
Based on simple revenue values I sorted out the top 17 Pharmaceutical
companies of India. Followed by that gathered data of Table 1 from
Moneycontrol.com, Forbes2000, Companys Annual Reports, Google
Market Cap Data and also used the official patent list provided by Indian
Patent Office (The link is provided above in the table 1).
I have incorporated the following parameters while ranking the
Companies

1. Financial performance
2. Value perceived by share holders
3. Consistency in Performance
4. Net Revenue
5. Profit being made
6. And innovation/extent of research
and development

Market

Revenue
Profit
No. of Patents

While doing the final ranking I allotted the following weightages

to the above discussed parameters to determine a consolidated

ranking index
Market Capitalization
Revenue
Profit
Patents in their name

30%
40%
10%
20%

And the calculation helped me to generate the list of THE TOP 10

PHARMACEUTICAL COMPANIES OF INDIA .And Here we go with
detailed list.

#10 IPCA LABORATORIES :

Ipca Laboratories is an international pharmaceutical company based in

Mumbai, India. It is also one of the largest suppliers of these APIs and their
intermediates world over. The various products of the company include
formulations, drug intermediates, and Active Pharmaceutical
Ingredients (API). It was founded by group of businessmen and medical
professionals in 1949. In 1975, the management of the company was
taken over by Amitabh Bachchan, Ajitabh Bachchan, Jaya Bachchan,
M.R. Chandurkar, P.C. Godha. IPCA is evolving rapidly. Their stature as a
pharmaceutical company that partners healthcare globally,while being
driven by quality, continues to grow with each passing day. Their brand
identity as evolved too. Modern, dynamic yet warm and
friendly, energetic yet sensitive, Their new identity is an expression of
the IPCA of today... an organization that works as equal partners with
global pharmaceutical leaders.
Ipca manufactures over 350 formulations in virtually every dosage form:
oral solids and liquids, dry powders for suspension, and injectables (liquid
and dry). Their renowned products are Zerodol, Lariago, Perinorm,
Etova, Folitrax, Malirid etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 3234.82Crores
INR. 8400.44Crores
INR. 477.34Crores
10
3863.797

#09 WOCKHARDT:

Wockhardt, headquartered in Mumbai, India, is a global pharmaceutical

and biotechnology organisation, providing affordable, high-quality
medicines for a healthier world. It is Indias leading research-based global
healthcare enterprise with relevance in the fields of Pharmaceuticals,
Biotechnology and a chain of advanced Super Speciality Hospitals.
Wockhardt is a true Indian Multi-National Company with a multi-ethnic
workforce of 8600 Wockhardt Associates from 21 different nationalities
globally. It has 3 research centres and 12 manufacturing plants, with
businesses ranging from the manufacture and marketing of
Pharmaceutical and Bio-pharmaceutical formulations, Active
Pharmaceutical Ingredients (APIs) and Vaccines. Wockhardt was founded
by Habil Khorakiwala in the early 1960s. His father Fakhruddin T.
Khorakiwala had acquired Worli Chemical Works in 1959. Wockhardt
works with partners to in-license products in India and out-license
products into other regions by capitalising on these collaborative
strengths to capture and penetrate new markets.
Their most renowned brands are Aceroc, Ace Proxyvon, Biovac-B,
Brozedex, Cavidin INH etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 1805.27Crores
INR. 14423.95Crores
INR. 198.61Crores
5
5070.154

#08 TORRENT PHARMACEUTICALS

LTD:

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent

Group. Based in Ahmedabad, it was promoted by U. N. Mehta initially as
Trinity Laboratories Ltd. and was later renamed to its current name
Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 50 countries with over
1000 product registrations globally. The company's key areas are
Formulations, API, Drug Discovery, Marketing and Sales of Drugs.
Moreover, it has 7 fully owned subsidiaries:
1. Heumann Pharma GmbH & Co Generica KG, Germany
2. Torrent Pharma GmbH, Germany
3. Torrent do Brasil Ltda., Brazil
4. ZAO Torrent Pharma, Russia
5. Torrent Pharma Inc., United States
6. Torrent Pharma Philippines Inc., Philippines
7. Torrent Pharma Canada Inc., Canada
Torrent Pharmaceuticals acquired Heumann GmbH, a Pfizer group
company in 2005.

Some of the renowned products of them are Nicorandil, Risperidone,

Lamotrigine, Esomeprazole Sodium etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 3364.87Crores
INR. 21263.68Crores
INR. 762.34Crores
6
7802.486

#07 GLAXOSMITHKLINE
PHARMACEUTICALS LTD:

Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals

Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company. At
GSK, our mission is to improve the quality of life by enabling people to do
more, feel better and live longer. This mission drives us to make a real
difference to the lives of millions of people with our commitment to
effective healthcare solutions.
The GSK India product portfolio includes prescription medicines and
vaccines. Our prescription medicines range across therapeutic areas such
as anti-infectives, dermatology, gynaecology, diabetes, oncology,
cardiovascular disease and respiratory diseases. The company is
the market leader in most of the therapeutic categories in which it
operates. GSK also offers a range of vaccines, for the prevention of
hepatitis A, hepatitis B, invasive disease caused by H, influenzae,
chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical
cancer, streptococcus pneumonia and others.
Their product portfolio includes Calpol, Neosporin-H ointment,
Phexin, Zovirax, Benitec, Carzek, Hiberix, Havrix etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit
Total No. of Patents in their name

INR. 2546.15Crores
INR. 27415.83Crores
INR. 501.88Crores
48

Consolidated Ranking Index

9302.997

#06 CADILA PHARMACEUTICALS:

Cadila Pharmaceuticals Ltd. is one of the largest privately held

pharmaceutical companies in India, headquartered at Ahmedabad, in
the State of Gujarat. Over the last six decades, the company has been
developing and manufacturing pharmaceutical products in India and
selling and distributing these in over eighty-five other countries around
the world.Focused strongly on Innovation and Research, the company is
present in more than forty-five therapeutic areas spread across
twelve specialities, including cardiovascular, gastrointestinal, analgesics,
haematinics, anti-infectives and antibiotics, respiratory agents,
antidiabetics and immunologicals.
At Cadila Pharmaceuticals, Research and Development is at the core of all
its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture
or Phytochemistry.The company has strong foothold in the African
continent through its formulation manufacturing facility at Addis Ababa in
Ethiopia.
Their extensive range of finished dosage formulations covers every
aspect of human life. Their basket of formulations contain more than 850
products in several forms belonging to 45 therapeutic segments and 12
specialities including cardiovascular, gastrointestinal, analgesics,
haematinics, anti-infectives and antibiotics, respiratory agents,
antidiabetics, immunogicals and oncology.
Some of the well-known brands of them are Acenext, Cadicoff, Exenot,
Eplecard, Glista etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit

INR. 9380.29Crores
INR. 34558.54Crores
INR. 903.6Crores

Total No. of Patents in their name

Consolidated Ranking Index

17
12078.162

#05 AUROBINDO PHARMA:

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda

Reddy and a small group of highly committed professionals, Aurobindo
Pharma was born off a vision. The company commenced operations in
1988-89 with a single unit manufacturing Semi-Synthetic Penicillin
(SSP) at Pondicherry.Aurobindo Pharma became a public company in
1992 and listed its shares in the Indian stock exchanges in 1995. In
addition to being the market leader in Semi-Synthetic Penicillins, it has a
presence in key therapeutic segments such as neurosciences,
cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology
and cephalosporins, among others.
Through cost effective manufacturing capabilities and a few loyal
customers, the company entered the high margin specialty generic
formulations segment. It is R&D focused and has a multi-product
portfolio with manufacturing facilities in several countries. It aims to
achieve USD 2 billion revenues by 2015-16. Aurobindo exports to
over 125 countries across the globe with more than 70% of its revenues
derived out of international operations.
Its best known brands are Aurox, Cedbrox, Tripcut, Cefactam, ProxtL,
AxtL, Recipro, Diceta etc.
THE FACT SHEET
Revenues
Market Capitalization

INR. 9380.29Crores
INR. 54922.49Crores

Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 1388.34Crores
1
14801.865

#04 CIPLA:

Cipla is a global pharmaceutical company whose goal is ensuring no

patient shall be denied access to high quality & affordable medicine and
support. Ciplas mission is to be a leading global healthcare company
which uses technology and innovation to meet everyday needs of all
patients.It was incorporated in the year of 1935. Headquartered at
Mumbai,India ,with an employee base of 20000+ Cipla focuses on
continuous innovation in R &D with 30+ world firsts. Its product
portfolio includes over 1,500 products across various therapeutic
categories, with 60+ dosage forms. It has a remarkable presence in over
150 countries.
It has International Approvals from US FDA, WHO-Geneva, MHRA-UK,
TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCCSouth Africa, PIC-Germany, Danish Medical Agency, ANVISABrazil, INVIMA- Colombia, NDA-Uganda, Department of HealthCanada and MOH-Saudi Arabia, among others
Some of its revolutionary brands are Acarboze, Natamycin,Terazocin,
Ciclesonide etc
THE FACT SHEET
Revenues
Market Capitalization
Profit

INR. 7110.71Crores
INR. 39467.24Crores
INR. 1172.09Crores

Total No. of Patents in their name

Consolidated Ranking Index

19
20371.497

#03 DR. REDDYS LABORATORIES

LTD:

Dr. Reddy's Laboratories, is a multinational pharmaceutical company

based in Hyderabad, Telangana, India. The company was founded
by Anji Reddy. Dr. Reddy's manufactures and markets a wide range of
pharmaceuticals in India and overseas. The company has over 190
medications, 60 active pharmaceutical ingredients (APIs) for drug
manufacture, diagnostic kits, critical care, and biotechnologyproducts. In
2014, Dr. Reddy Laboratories was listed among 1200 of India's most
trusted brands according to the Brand Trust Report2014.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon
started exporting to other less-regulated markets to gain approval from a
drug licensing body such as the U.S. Food and Drug
Administration (FDA). By 2007, Dr. Reddy's had six FDA plants
producing active pharmaceutical ingredients in India and seven FDAinspected and ISO 9001 (quality) and ISO 14001 (environmental
management) certified plants making patient-ready medications five of
them in India and two in the UK.

Some of their best-selling brands are Allopurinol tablets, Ciprofloxacin

Tablets, Clopidogrel Tablets, Famotidine Tablets, Fluoxetine
Capsules etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 9993.9Crores
INR. 59490.29Crores
INR. 1932.8Crores
21
22042.127

#02 LUPIN PHARMACEUTICALS, Inc:

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin

Limited.Through sales and marketing headquarters in Baltimore, MD,
Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality,
branded and generic medications trusted by healthcare professionals and
patients across geographies.
Lupin Limited, headquartered in Mumbai, India, is strongly research
focused. It has a program for developing New Chemical Entities. The
company has a state-of-the-art R&D center in Pune and is a leading global
player in Anti-TB, Cephalosporins (anti-infectives) and
Cardiovascular drugs (ACE-inhibitors and cholesterol reducing
agents) and has a notable presence in the areas of diabetes, antiinflammatory and respiratory therapy.It has the distinction of being the
fastest growing generic pharmaceutical player in the two largest
pharmaceutical markets of the world the US and Japan; and is the
4th largest and the fastest growing generic pharmaceutical
player in South Africa. Lupins research program covers the entire
pharma value chain. The companys global R&D program is headquartered
in the Lupin Research Park located near Pune that houses over 1400
scientists.
Some of its well-recognized brands are Norvasc, Trizivir, Creftin.
Lexapro, Mevacor, Pravacol etc.
THE FACT SHEET
Revenues

INR. 8939.38Crores

Market Capitalization
Profit
Total No. of Patents in their name
Consolidated Ranking Index

INR. 75743.15Crores
INR. 2324.22Crores
6
26532.325

#01 SUN PHARMACEUTICAL

INDUSTRIES LTD:

Sun Pharmaceutical Industries Limited is a

multinational pharmaceutical company headquartered in Vadodara,
Gujarat that manufactures and sells pharmaceutical formulations and
active pharmaceutical ingredients (APIs) primarily in India and the United
States. The company offers formulations in various therapeutic areas,
such
as cardiology,psychiatry, neurology, gastroenterology and diabet
ology. It also provides APIs such as warfarin, carbamazepine,
etodolac, and clorazepate, as well as anticancers, steroids,
peptides, sex hormones, and controlled substances.
Sun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983
in Vapi with five products to treat psychiatry ailments. Cardiology
products were introduced in 1987 followed by gastroenterology products
in 1989. Today it is the largest chronic prescription company in
India and a market leader in psychiatry, neurology,
cardiology, orthopedics, ophthalmology, gastroenterology andnephrology.
The 2014 acquisition of Ranbaxy will make the company the largest
pharma company in India, the largest Indian pharma company in
the US, and the 5th largest speciality generic company globally.
Some of its best-selling products are Adcapone, Alzolam, Angizem,
Aztor etc.
THE FACT SHEET
Revenues
Market Capitalization
Profit

INR. 2828.79Crores
INR. 227755.94Crores
INR. -2828.52Crores

Total No. of Patents in their name

Consolidated Ranking Index

10
69177.446